• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 32 páginas
Examen

ABFM ITE Exam V1 (Latest Update 2026 / 2027) | Questions & Answers | Grade A | 100% Correct

Document preview thumbnail
Vista previa 4 fuera de 32 páginas

ABFM ITE Exam V1 (Latest Update 2026 / 2027) | Questions & Answers | Grade A | 100% Correct Question: Dermatitis herpetiformis (clusters of pruritic lesions) is associated with what condition? Answer: Celiac disease. Question: Patient at 36 weeks gestation has itchiness in palms and soles. Next step? Answer: Check bile acid levels. - Intrahepatic cholestasis of pregnancy (ICP): pruritus of palms/soles with or without jaundice, elevated serum bile acid. MC in late 2nd and/or 3rd trimester. Can cause significant risk to the fetus, including fetal death. Treated aggressively with ursodeoxycholic acid and often early delivery. Question: when to use omalizumab for asthma? Answer: Severe type 2 inflammatory asthma poorly controlled with optimal therapy with long term medication, including high-dose corticosteroids and long acting B agonist. - According GINA guidelines, Management of severe asthma includes determination of the asthma phenotype to assess for type 2 inflammation. - Type 2 asthma includes allergic and eosinophilic asthma. (Elevated serum eosinophils, elevated fractional exhaled nitric oxide).

Vista previa del contenido

ABFM ITE Exam V1 (Latest Update
) | Questions & Answers
| Grade A | 100% Correct


Question:
Dermatitis herpetiformis (clusters of pruritic lesions) is associated with what
condition?
Answer:
Celiac disease.




Question:
Patient at 36 weeks gestation has itchiness in palms and soles. Next step?
Answer:
Check bile acid levels.


- Intrahepatic cholestasis of pregnancy (ICP): pruritus of palms/soles with or
without jaundice, elevated serum bile acid. MC in late 2nd and/or 3rd
trimester. Can cause significant risk to the fetus, including fetal death.
Treated aggressively with ursodeoxycholic acid and often early delivery.

,Question:
when to use omalizumab for asthma?
Answer:
Severe type 2 inflammatory asthma poorly controlled with optimal therapy
with long term medication, including high-dose corticosteroids and long
acting B agonist.


- According GINA guidelines, Management of severe asthma includes
determination of the asthma phenotype to assess for type 2 inflammation.
- Type 2 asthma includes allergic and eosinophilic asthma. (Elevated serum
eosinophils, elevated fractional exhaled nitric oxide).


- Non-type 2 asthma is driven by neutrophils and is associated with smoking
and obesity.




Question:
Persistent HTN is defined as ______.
Answer:
HTN despite 3 or more antiHTN rx, including a diuretics

,Question:
Best Evidence based treatment for Frailty syndrome?


A) Protein supplements
B) Vitamin D supplements
C) Hormonal treatment with anabolic steroids
D) Aerobic conditioning training
E) Progressive resistance training
Answer:
E) Progressive resistance training.


- Aerobic conditioning training may be helpful but NOT the strongest
evidence for efficacy.


- Routine use of protein supplements, vit D, or hormonal tx (anabolic
steroids) is NOT recommended.

, Question:
TSH 0.04, fT3 is 3.4, fT4 is 1.4 and RAIU scan shows multiple areas of
increased and suppressed uptake. Dx?


A) Exogenous thyroid hormone use
B) Graves
C) Painless thyroiditis
D) Excess iodine intake
E) Toxic multinodular goiter
Answer:
E) Toxic multinodular goiter.


- Low TSH, normal fT3/4 consistent with subclinical hyperthyroidism.
- RAIU shows multiple areas of INCREASED and SUPPRESSED uptake is
consistent with toxic multinodular goiter.
- Etiology determined by clx sxs, biochemical markers, and diagnostic studies
(RAIU) if indicated. If TSH persistently <0.1, the American Thyroid Assoc has
a strong recommendation with moderate-quality evidence for treating pt 65+
yoa, h/o cardiac risk factors, heart disease, osteoporosis, postmenopausal
women not on estrogen/ bisphosphonate or those with hyperthyroid sxs.


- There is no RAIU uptake with exogenous thyroid hormone ingestion,
painless thyroiditis, or excess iodine intake.
- Graves disease causes DIFFUSE RAIU!!!!!

Información del documento

Subido en
25 de febrero de 2026
Número de páginas
32
Escrito en
2025/2026
Tipo
Examen
Contiene
Preguntas y respuestas
$10.99

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
quiz_bit
3.9
(1924)
Vendido
12152
Seguidores
5235
Artículos
7594
Última venta
23 horas hace




Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes